JCB, Volume 15, Number 1, 2009 Editorial Vol.15 No. 1 (2009) Biotechnology commercialisation: Getting past the technology-push Yali Friedman   Article Vol.15 No. 1 (2009) Record integrity and licensing your intellectual property John Avellanet For the biotechnology executive looking to cut a deal with a pharmaceutical company, it is not the type of new molecule that matters, but the quality of the records and Article Vol.15 No. 1 (2009) NIH assistance for new therapeutic development: NIH-RAID Pilot Program David G Badman The National Institutes of Health (NIH) wishes to alert the biotech/medical research community to an opportunity to obtain assistance in the dev Article Vol.15 No. 1 (2009) Parallel imports: Towards a flexible uniform international rule Stefan M Miller Parallel imports are goods that are placed into a market in one country which subsequently are traded without the authorisation of the holder of intellectual property r Article Vol.15 No. 1 (2009) Pharmaceutical patents after KSR: What is not obvious? Jason Lief The Supreme Court recently revisited the question of patent validity based upon obviousness in KSR Int'l v Teleflex, Inc. The court rejected the Federal Circuit' Article Vol.15 No. 1 (2009) ATMP in practice: Towards a new industry landscape in tissue engineering Laure Brévignon-Dodin Regulatory divergences and market fragmentation across member states have hampered the development of the tissue engineering industry in the EU. Addressing this situati Article Vol.15 No. 1 (2009) Thailand biotech business: Product of the national policy Nataporn Chanvarasuth Thailand's National Biotechnology Policy Framework 2004–2009 acts as a catalyst to enhance industrial productivity and sustainability. Six goals are identified i From the Classroom Vol.15 No. 1 (2009) Teaming in biotechnology commercialisation: The diversity-performance connection and how university programmes can make a difference Anne S York Collaboration across disciplines in the sciences is on the rise. Yet, practitioner papers abound that describe a range of dysfunctional team experiences, especially in Legal and Regulatory Updates Vol.15 No. 1 (2009) Legal and regulatory update John Wilkinson Book Review Vol.15 No. 1 (2009) Book Review: Science lessons: What biotech taught me about management Arthur A Boni Science lessons: What biotech taught me about managementGordon Binder and Philip BasheHarvard Business School Press, Boston, MA, 2008, hardback, 288pp.ISBN: 978-15913 Book Review Vol.15 No. 1 (2009) Book Review: Essentials of pharmacoeconomics Harley King Essentials of pharmacoeconomicsKaren L. RascatiLippincott Williams & Wilkins, Baltimore, 2008, paperback, 250pp.,ISBN: 978-0781765442
